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Using Virtual Technology to Preserve the Lifespan of Central
Venous Access Devices

The Effect of the COVID-19 Pandemic in Intestinal
Rehabilitation and Transplant Patients, Initial Results of an
International Survey

Cole A1, Naik S1, Patel M1, Shah J1, Mcconnell R1
Barts Health - The Royal London Children’s Hospital
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Aim: To use a web based management platform to prevent occlusions and
preserve the lifespan of a central venous access devices (CVAD) for Home
Parenteral Nutrition (HPN).
Background: Despite many techniques, adjuncts and pharmaceutical
agents there are some CVADs that remain troublesome with frequent partial and full occlusions that require CVAD exchanges. The CVAD for a child
or young person that requires HPN can be described as a “lifeline” and all
options to maintain long term patency should be utilised. MicrelCare have a
web based care management platform that monitors real time infusion pressures relaying information from the home to the hospital
Methodology: Using one teenage male on HPN (who had experienced
3 CVAD exchanges in 2 years) as a candidate for MicrelCare, we virtually
monitored his CVAD pressure’s and infusion alarms via a real time platform. This virtual platform alongside clinical correlation (patient consultations and physical assessment) allowed for the determination of pressure
range monitoring and the early detection of line stiffness and pre cursors
to occlusion.
Results: We were able to determine that for this patient when the CVAD
pressure levels reached 0.2 bar it was imperative that we physically assessed
the CVAD and followed the in house protocol of Urokinase/Alteplase instilment followed by an Ethanol treatment if required (including hub inspection
and POP technique) to prevent irreversible occlusion.
Interestingly the pressure bar for this young man is lower than MicrelCare
would expect and that of our patient cohort.
Conclusion: MicrelCare can be a useful tool to virtually monitor and predict
precursors to CVAD stiffness and occlusion when used with clinical correlation.This allows the development of a robust tailored care plan, which prolongs the life of a CVAD and in turn preserves venous access.
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Introduction: On January 30, 2020 the World Health Organization (WHO)
declared the 2019-CoV outbreak in China as a global public health emergency and subsequently, a pandemic on March 11th. It was considered that
intestinal failure and intestinal transplant patients might have a higher risk of
severe complications from the COVID-19 disease, multidisciplinary intestinal
failure teams had to adapt their clinical approaches in order to keep this vulnerable group of patients as safe as possible during the pandemic; but data
was lacking. Therefore, in order to improve our knowledge, we designed a
voluntary, international survey aiming to address the impact of the COVID-19
disease in intestinal failure and transplant patients worldwide.
Patient and Methods: A retrospective, observational, multicenter survey was sent to all centers registered at the Intestinal Rehabilitation and
Transplant Association (IRTA).
The survey contained three modules: the 1st one consisted of 14 questions
about the hospital’s activity during the COVID-19 pandemic. The 2nd one,
contained 43 questions, was about intestinal failure patient management
and outcome and the 3rd one (52 questions) focused on intestinal transplant
patients. We used the Google Form platform. We aim to present the preliminary results of the first module. Statistical analysis was performed with the
IBM SPSS Statistic version 25.0® program.
Results: 13/42 (41%) centers responded; including centers from France,
Netherlands, Italy, United States, UK, Sweden, Germany and Argentina.
Only 2 centers reported moratorium on intestinal (IT) or multivisceral transplant (MVT), with a mean of 3 months (±4) [Table 1]. Since the pandemic
started, 2 institutions reported 4 patients with intestinal rehabilitation or on
TPN diagnosed with COVID-19 while 7 centers hospitals claimed to have
had 9 patients post-IT/MTV affected by the disease. While 7 centers had their
routine follow up and “protocol biopsies” in the post-IT/MTV affected, none
reported higher rates of rejection or complications. At the same time, 8 centers (77%) were affected by a mean of 15% decrease in referrals for new evaluations of intestinal failure or transplantation (compared to 2019) [Figure 1].
All centers adapted to utilizing telemedicine to follow up on IT/MVT patients.

TABLE 1.

Moratorium for listing patients by center.
Moratorium

Patients listed for isolated intestine/non liver-containing
graft transplant
Patients with cirrhosis and a MELD-Na score <20 listed
for a multivisceral transplant
Patients with cirrhosis and a MELD-Na score >20 listed
for a MVT
Patients without cirrhosis and a MELD-Na score <20 listed
for a MVT
Patients without cirrhosis and a MELD-Na score >20 listed
for a MVT
No moratorium

Centers (N)

5/13
2/13
2/13
2/13
1/13
7/13
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Figure 1. Percentage of centers affected by a reduction in the
number of referrals for evaluation in comparison with 2019.
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Conclusions: Many aspects of healthcare have been impacted by the
COVID-19 pandemic. The survey showed that the number of affected
patients has been lower than expected, the reduced number of centers
required transient moratorium of their activity, but a secondary observation
was that despite the availability of telemedicine, and probably related to the
lockdown, there has been a significant reduction in the referrals for evaluation of intestinal failure and transplant patients, that may have the deleterious
effect of the delay of treatment in health care system.

Objective: Home Parenteral Nutrition (HPN) is the cornerstone management
for children suffering from chronic intestinal failure (CIF). In France, HPN is
organized from a network of 7 certified centers located in University Hospitals
spread across the national territory. This study aims to review the data involving children on HPN over a 6-years period in France.
Population and methods: This cross-sectional study included all children enrolled in any of the 7 French HPN certified centers from January 1st,
2014 to December 31st, 2019. Data was recorded from annual databases
provided by each center regarding: age at inclusion, indication and duration of HPN, type of intravenous lipid emulsion (ILE), outcome [PN weaning off, transfer to adult center, death, intestinal transplantation (ITx)], rate
of catheter-related bloodstream infections (CRSBIs) for 1000 days of HPN,
Taurolidine lock procedure (TLP) use and prevalence of cholestasis defined
as conjugated bilirubin ≥ 20µmol/l.
Results: According to the year of follow up, the indications for HPN were
short bowel syndrome (SBS) (42.3-46.6%), congenital enteropathies (CE)
(18.5-22.8%), chronic intestinal pseudo-obstruction syndrome (CIPOS)
(13.0-16.3%), long segment Hirschsprung’s disease (LSHD) (9.7 - 13.3%),
Crohn’s disease (CD) (1.6-2.6%) and other non-primary digestive diseases
(NPDD) such as immune deficiency, cancer or metabolic disease (4.09.2%). The median age at discharge on HPN tended to decrease from
11.7 months in 2014 to 8.3 months in 2019 (p<.001). By December 31st,
2019, 44.8% of children had left the HPN program after a duration ranging between 48.1 ± 33.7 and 71.1 ± 22.8 months. Among these patients,
192 patients (74.2%) were weaned off PN (94.7% SBS), 41 (15.8%) were
transferred to adult centers for CIPOS (42%), SBS (31%) or CE (27%), 21
died (8.1%) - mostly in relation to cancer or immune deficiency - and 5
were transplanted (1.9%): 4 combined liver-intestine for LSHD (n=2), SBS,
CE and one multivisceral Tx for CIPOS. The use of a composite fish-oil
based ILE increased from 67.4 % in 2014 to 88.3 % in 2019 (p<.001).
CRBSIs dropped from 1.04 CRSBIs per 1000 days HPN in 2014 to 0.61
in 2019 (p<.001) while meantime, the percentage of children receiving TLP
increased from 29.4 % to 63.0 % (p<.001). The prevalence of cholestasis
(conjugated bilirubin ≥ 20µmol/l) was low and stable between 4.1 and 5.9%
of children during the study period.
Conclusion: In France, the number of children enrolled in a HPN program
continuously increased over the 6 years period. SBS is the leading cause of
CIF requiring HPN. The rate of CRBSIs dropped dramatically as the use of
TLP increased. Mortality rate was low and mainly in relation to the underlying
disease (cancer, immune deficiency). Cholestasis and intestinal Tx remained
very rare. This could be explained by the low incidence of CRSBIs and the
wide use of fish-oil based ILE.

